Polaryx Therapeutics, Inc. (NASDAQ:PLYX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Charles Ryan Other companies: Quince Therapeutics, Inc. (President · Since at least Sep 1, 2023); Neurotrope Inc (Director · Dec 14, 2017 – Dec 1, 2020 · Past); BioRestorative Therapies, Inc. (Director · Apr 6, 2015 – Mar 25, 2019 · Past); BNB Plus Corp. (Director · Nov 14, 2014 – May 17, 2019 · Past) | Director · Since at least Jan 29, 2026 |
| Francis A Braun III Other companies: ITG, Inc. (Director · Since at least Jul 1, 2026); Elite Express Holding Inc. (Director · Since at least Aug 20, 2025); SHF Holdings, Inc. (Director · Since at least Aug 7, 2025) | Director · Since at least Jan 29, 2026 |
| G. Michael Landis Other companies: Lannett Company Inc (Principal Accounting Officer · Apr 24, 2012 – Jul 1, 2020 · Past) | Chief Financial Officer · Since at least Jan 29, 2026 |
| Lisa Bollinger Other companies: Apogee Therapeutics, Inc. (Director · Since at least May 28, 2024) | Chief Medical Officer · Since at least Jan 29, 2026 |
| Alex Keun Mo Yang | Chief Executive Officer, Director · Since at least Jan 29, 2026 |
| Alex Yang | CEO and Chair of the Board · Since at least Sep 1, 2026 |
| Andrew John O | Chief Investment Officer · Since at least Jan 29, 2026 |
| Eddy Zhu | Chief CMC Officer · Since at least Nov 4, 2026 |
| Francis A. Braun | Director · Since at least Feb 5, 2026 |
| Minsu Kang | Vice President, Clinical Development and Regulatory Affairs · Since at least Mar 12, 2026 |
| Mitchel Berger | Director · Since at least Jan 29, 2026 |
| Shrijay Vijayan | Chief Scientific and Business Development Officer · Since at least Mar 12, 2026 |
| Will Charlton | Chief Medical Officer · Since Sep 1, 2026 · Appointed, no departure found |
| Will Charlton | Chief Medical Officer · Since at least Sep 1, 2026 |